MedTrace Logo

Use of Dexcom G6 in Commercial Pilots With Insulin Treated Diabetes

NCT04395378 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-04-29

No results posted yet for this study

Summary

The investigators wish to explore the use of the CGMS Dexcom G6® in pilots with insulin-treated diabetes, who are flying commercial aircraft with Class 1 and flying instructors or private pilots with class 2 certificates.

The aim of this study is to explore the severity and number of hypoglycaemic episodes recorded with rtCGMS compared to the results from other self-glucose monitoring following the current protocol of the UK Civil Air Aviation (UKCAA), and to explore the possibility of the use of rtCGMS during flight and free living.

This will involve using CGM Dexcom G6® for continuous glucose monitoring for 6 months in flight time and during free living. The participants will be blinded for the results for the first month but will be encouraged to use the data from the CGMS Dexcom G6 ® for the following 5 months during the trial.

Conditions

Interventions

DEVICE

Continuous Glucose monitoring DEXCOM G6

Continuous glucose monitoring during flight and normal living life

Sponsors & Collaborators

  • UK Civil Aviation Authority

    collaborator UNKNOWN

  • Irish Civil Aviation Authority

    collaborator UNKNOWN

  • Austrian Civil Aviation Authority

    collaborator UNKNOWN

  • University of Surrey

    lead OTHER

Principal Investigators

  • David Russell-Jones, BSc · University of Surrey

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-05
Primary Completion
2022-12-02
Completion
2022-12-02
FDA Device
Yes

Countries

  • Austria
  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04395378 on ClinicalTrials.gov